Prevalence and predictors of mind-body medicine use among women diagnosed with gynecological cancer: Findings from the 2017 US National Health Interview Survey.

Wong, CHL; Sundberg, T; Chung, VCH; Voiss, P; Cramer, H

Prevalence and predictors of mind-body medicine use among women diagnosed with gynecological cancer: Findings from the 2017 US National Health Interview Survey.

Wong, CHL Sundberg, T Chung, VCH Voiss, P Cramer, H

Permalink

Publisher:: ACADEMIC PRESS INC ELSEVIER SCIENCE
Publication Type:: Journal Article
Citation:: Gynecologic oncology, 2020, 157, (3), pp. 740-744
Issue Date:: 2020-06

Closed Access

	Filename	Description	Size
	1-s2.0-S0090825820302274-main.pdf	Published version	429.7 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wong, CHL
dc.contributor.author	Sundberg, T
dc.contributor.author	Chung, VCH
dc.contributor.author	Voiss, P
dc.contributor.author	Cramer, H
dc.date.accessioned	2020-09-02T02:18:52Z
dc.date.available	2020-03-08
dc.date.available	2020-09-02T02:18:52Z
dc.date.issued	2020-06
dc.identifier.citation	Gynecologic oncology, 2020, 157, (3), pp. 740-744
dc.identifier.issn	0090-8258
dc.identifier.issn	1095-6859
dc.identifier.uri	http://hdl.handle.net/10453/142493
dc.description.abstract	BACKGROUND:Gynecological cancer is a major health burden globally. In the US, it is common for cancer patients to utilize different types of complementary medicine. This study aims to investigate the prevalence of mind-body medicine use among US women diagnosed with gynecological cancer. METHODS:We used data from the 2017 National Health Interview Survey (NHIS) to investigate prevalence and predictors of mind-body medicine utilization in the past 12 months among gynecological cancer patients in a representative sample of the US population (N = 26,742). We descriptively analyzed the 12-month prevalence of any mind-body medicine use, separately for women with a prior diagnosis of gynecological cancer and those without. Using and b multiple logistic regression analyses, we identified predictors of mind-body medicine use. RESULTS:A weighted total of 2,526,369 women (2.0%) reported having received a diagnosis of gynecological cancer. More women diagnosed with gynecological cancer (weighted n = 964,098; 38.2%) than those not diagnosed with gynecological cancer (weighted mean = 36,102,852; 28.8%) had used mind-body medicine in the past 12 months. A higher prevalence of mind-body medicine use was associated with being non-Hispanic White, living in Western US and having received higher education. Spiritual meditation was found to be the most frequently used mind-body medicine modality, followed by yoga and progressive relaxation. CONCLUSIONS:While mind-body medicine is popular among US gynecological cancer patients, clinical evidence supporting the effectiveness of different mind-body medicine modalities is yet to be established. Randomized controlled trials should be conducted to evaluate the effectiveness of popular modalities like spiritual meditation or yoga to inform clinical decision and patient choice.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ACADEMIC PRESS INC ELSEVIER SCIENCE
dc.relation.ispartof	Gynecologic oncology
dc.relation.isbasedon	10.1016/j.ygyno.2020.03.011
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.subject	1112 Oncology and Carcinogenesis, 1114 Paediatrics and Reproductive Medicine
dc.subject.classification	Oncology & Carcinogenesis
dc.title	Prevalence and predictors of mind-body medicine use among women diagnosed with gynecological cancer: Findings from the 2017 US National Health Interview Survey.
dc.type	Journal Article
utslib.citation.volume	157
utslib.location.activity	United States
utslib.for	1112 Oncology and Carcinogenesis
utslib.for	1114 Paediatrics and Reproductive Medicine
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2020-09-02T02:18:45Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	157
utslib.citation.issue	3

Abstract:

BACKGROUND:Gynecological cancer is a major health burden globally. In the US, it is common for cancer patients to utilize different types of complementary medicine. This study aims to investigate the prevalence of mind-body medicine use among US women diagnosed with gynecological cancer. METHODS:We used data from the 2017 National Health Interview Survey (NHIS) to investigate prevalence and predictors of mind-body medicine utilization in the past 12 months among gynecological cancer patients in a representative sample of the US population (N = 26,742). We descriptively analyzed the 12-month prevalence of any mind-body medicine use, separately for women with a prior diagnosis of gynecological cancer and those without. Using and b multiple logistic regression analyses, we identified predictors of mind-body medicine use. RESULTS:A weighted total of 2,526,369 women (2.0%) reported having received a diagnosis of gynecological cancer. More women diagnosed with gynecological cancer (weighted n = 964,098; 38.2%) than those not diagnosed with gynecological cancer (weighted mean = 36,102,852; 28.8%) had used mind-body medicine in the past 12 months. A higher prevalence of mind-body medicine use was associated with being non-Hispanic White, living in Western US and having received higher education. Spiritual meditation was found to be the most frequently used mind-body medicine modality, followed by yoga and progressive relaxation. CONCLUSIONS:While mind-body medicine is popular among US gynecological cancer patients, clinical evidence supporting the effectiveness of different mind-body medicine modalities is yet to be established. Randomized controlled trials should be conducted to evaluate the effectiveness of popular modalities like spiritual meditation or yoga to inform clinical decision and patient choice.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/142493